Intragenic ERBB2 kinase mutations in tumoursPhilip Stephens, Marco A. Pierotti, Kelly Halliday et al.|Nature|2004Cited by 790
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Oncogenic FGFR3 gene fusions in bladder cancerSarah V. Williams, Margaret A. Knowles|Human Molecular Genetics|2012Cited by 378
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivoFiona R. Lamont, Margaret A. Knowles|British Journal of Cancer|2010Cited by 178
A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA geneCarolyn D. Hurst, Margaret A. Knowles, Tahlita C.M. Zuiverloon et al.|BMC Research Notes|2009Cited by 98